论文部分内容阅读
目的:观察参芪健脾汤联合化疗治疗非小细胞肺癌脾气虚证的临床疗效及对免疫功能的影响。方法:将56例非小细胞肺癌脾气虚证患者随机分为两组,对照组28例采用单纯化疗,治疗组28例在化疗同时加用参芪健脾汤治疗,比较两组中医证候疗效、外周血淋巴细胞亚群及KPS评分。结果:总有效率治疗组为67.9%,对照组为42.9%,组间比较,差异有统计学意义(P<0.05);治疗组外周血淋巴细胞亚群各项指标除CD3外治疗前后组内比较及治疗后组间比较,差异均有统计学意义(P<0.05);KPS评分治疗组治疗前后组内比较,差异有统计学意义(P<0.05)。结论:参芪健脾汤治疗非小细胞肺癌有较好疗效,具有增强免疫功能的作用。
Objective: To observe the clinical efficacy of Shenqi Jianpi Decoction combined with chemotherapy in treating non-small cell lung cancer with spleen deficiency syndrome and its effect on immune function. Methods: 56 cases of non-small cell lung cancer patients with spleen-qi deficiency were randomly divided into two groups, the control group of 28 patients with simple chemotherapy, the treatment group of 28 patients treated with chemotherapy plus Shenqi Jianpi Decoction, curative effect comparison of two groups of TCM , Peripheral blood lymphocyte subsets and KPS score. Results: The total effective rate was 67.9% in the treatment group and 42.9% in the control group. The difference between the two groups was statistically significant (P <0.05). The indexes of peripheral blood lymphocyte subsets in the treatment group were significantly higher than those before and after treatment with CD3 There were significant differences between the two groups after treatment (P <0.05). There was significant difference between before and after treatment in KPS group (P <0.05). Conclusion: Shenqi Jianpi Decoction is effective in treating non-small cell lung cancer and has the function of enhancing immune function.